Milnacipran belongs to the SNRI class of medications, functioning by balancing neurotransmitters in the brain. It is primarily indicated for treating major depressive episodes and managing fibromyalgia symptoms. As a key component in trusted generic treatments, it offers a cost-effective solution for long-term care. Our platform provides reliable access to a variety of medications containing Milnacipran, ensuring consistent quality for patients across the UK seeking effective mood and pain management.
Milnacipran belongs to a class of medicines called serotonin-noradrenaline re-uptake inhibitors (SNRIs). It works by gently increasing the activity of two natural chemicals in the brain that help regulate mood and pain. In the United Kingdom, milnacipran is available only as a prescription-only medicine and is approved by the MHRA for specific uses.
The most widely known product that contains milnacipran is Savella. Savella is supplied as delayed-release tablets and comes in several strengths, usually 50 mg and 100 mg. Both the brand-name version and the generic milnacipran tablets contain the same active ingredient, though the tablets may differ in colour or shape. Savella is the only milnacipran-based product currently marketed in the UK, and it is prescribed by specialists who manage chronic pain conditions.
Milnacipran is generally prescribed for adults who have been diagnosed with these conditions after a thorough medical assessment.
When milnacipran is taken, it blocks the re-absorption of serotonin and noradrenaline, allowing more of these neurotransmitters to remain active in the brain. This increase helps to modulate the way pain signals are processed, leading to a reduction in the perception of pain. Most patients notice a gradual improvement over several weeks, rather than an immediate effect.
Mild reactions are often reported and usually resolve on their own. Typical experiences include:
These effects are generally short-lived and may lessen as the body gets used to the medication.
Although rare, some reactions need urgent medical attention:
If any of these occur, prompt medical evaluation is essential.
People with certain health backgrounds should discuss milnacipran with a prescriber before starting:
Pregnancy and breastfeeding are also situations where milnacipran is usually avoided unless the benefits clearly outweigh the risks.
Milnacipran can interact with other medicines or substances that influence serotonin levels. Notable examples include:
Because interactions can vary between individual products, always check the specific medication’s information leaflets for a complete list.
Store milnacipran tablets in a cool, dry place away from direct sunlight and out of reach of children. The tablets are designed for regular, once-daily use, but the length of treatment differs from one product to another. Remember that the guidance on how to take Savella or any generic milnacipran tablet is provided on the individual medicine’s label. For detailed usage, dosing, and administration, refer to that specific information.
Serotonin-noradrenaline re-uptake inhibitor (SNRI): A type of medication that increases the levels of two brain chemicals, serotonin and noradrenaline, to help manage mood and pain.
Delayed-release tablet: A tablet formulated to release the active ingredient slowly over time, often taken once a day.
This article offers general educational information about milnacipran as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing milnacipran may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
